BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Genetown

  Korro to Present at the TD Cowen 44th Annual Health Care Conference

  Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., will present at the TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts, on Monday, March 4, 2024, at 2:10 p.m. ET.

  February 27, 2024

   · 

  1 min read
• Business

  iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

  iCAD, Inc. (NASDAQ: ICAD) announced today the Company will release financial results for the fourth quarter and full year 2023 financials after the market close, and host a conference call at 4:30 PM Eastern Time on Tuesday, March 12, 2024.

  February 27, 2024

   · 

  3 min read
• Business

  Plus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024

  Plus Therapeutics, Inc. today announced that the Company will report fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024, after market close.

  February 27, 2024

   · 

  4 min read
• Genetown

  Third Pole Therapeutics Announces Successful Completion of Feasibility Study with eNOfit™ Portable Inhaled Nitric Oxide Delivery System

  Third Pole Therapeutics announced today the successful completion of an early feasibility study (EFS) performed under an Investigational Device Exemption granted by the FDA.

  February 27, 2024

   · 

  5 min read
• Genetown

  Cullinan Oncology to Participate in Upcoming March 2024 Investor Conferences

  Cullinan Oncology, Inc. a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, announced its participation in the following upcoming investor conferences.

  February 27, 2024

   · 

  2 min read
• Pharm Country

  Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China

  Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China.

  February 27, 2024

   · 

  9 min read
• Business

  Vittoria Therapeutics Announces Appointment of Life Sciences Veteran Rosemary Mazanet, M.D., Ph.D. as Chief Medical Officer

  Vittoria Biotherapeutics has announced today that accomplished life sciences leader, Rosemary Mazanet, M.D., Ph.D., has joined the Company as Chief Medical Officer.

  February 27, 2024

   · 

  4 min read
• Deals

  Denali Therapeutics Announces $500 million Private Placement Equity Financing

  Denali Therapeutics Inc. today announced that the company has entered into a securities purchase agreement with certain existing accredited investors to issue and sell an aggregate of 3,244,689 shares of its common stock at a price of $17.07 per share.

  February 27, 2024

   · 

  6 min read
• Business

  Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

  Denali Therapeutics Inc. today reported financial results for the fourth quarter and year ended December 31, 2023, and provided business highlights.

  February 27, 2024

   · 

  17 min read
• BioMidwest

  AbbVie to Present at the TD Cowen 44th Annual Health Care Conference

  AbbVie (NYSE: ABBV) will participate in the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024.

  February 27, 2024

   · 

  1 min read